TIM
NVO

Thornburg Investment Management’s Novo Nordisk NVO Stock Holding History

Thornburg Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-544,386
Closed -$30.2M – 181
2025
Q3 		$30.2M Sell
544,386
-278,291
-34% -$16.3M 0.39% 42
2025
Q2 		$56.8M Buy
822,677
+104,842
+15% +$7.13M 0.73% 31
2025
Q1 		$49.8M Sell
717,835
-3,313
-0.5% -$274K 0.7% 32
2024
Q4 		$62M Sell
721,148
-38,043
-5% -$4.11M 0.82% 29
2024
Q3 		$90.4M Buy
759,191
+18,823
+3% +$2.51M 1.18% 24
2024
Q2 		$106M Sell
740,368
-21,345
-3% -$2.83M 1.49% 21
2024
Q1 		$97.8M Sell
761,713
-96,497
-11% -$11.5M 1.36% 22
2023
Q4 		$88.8M Sell
858,210
-39,691
-4% -$3.93M 1.28% 22
2023
Q3 		$81.7M Buy
897,901
+213,547
+31% +$18.8M 1.34% 21
2023
Q2 		$55.4M Buy
684,354
+50,940
+8% +$4.16M 0.9% 30
2023
Q1 		$50.4M Buy
633,414
+127,552
+25% +$9.04M 0.83% 30
2022
Q4 		$34.2M Buy
+505,862
New +$29.7M 0.58% 42
2016
Q4 		– Sell
-739,620
Closed -$15.4M – 277
2016
Q3 		$15.4M Sell
739,620
-302,770
-29% -$7.51M 0.12% 145
2016
Q2 		$28M Sell
1,042,390
-257,414
-20% -$7.06M 0.22% 104
2016
Q1 		$35.2M Sell
1,299,804
-83,316
-6% -$2.23M 0.23% 95
2015
Q4 		$40.2M Sell
1,383,120
-87,284
-6% -$2.42M 0.26% 91
2015
Q3 		$39.9M Sell
1,470,404
-75,064
-5% -$2.13M 0.25% 93
2015
Q2 		$42.3M Sell
1,545,468
-203,172
-12% -$5.71M 0.24% 100
2015
Q1 		$46.7M Sell
1,748,640
-1,882,088
-52% -$43.3M 0.26% 97
2014
Q4 		$76.8M Sell
3,630,728
-686,370
-16% -$15.3M 0.38% 72
2014
Q3 		$103M Sell
4,317,098
-1,041,376
-19% -$24M 0.46% 62
2014
Q2 		$124M Sell
5,358,474
-2,562,906
-32% -$56.6M 0.49% 58
2014
Q1 		$181M Sell
7,921,380
-1,742,390
-18% -$37.1M 0.71% 31
2013
Q4 		$179M Buy
9,663,770
+242,960
+3% +$4.23M 0.68% 32
2013
Q3 		$159M Buy
9,420,810
+113,290
+1% +$1.91M 0.64% 38
2013
Q2 		$144M Buy
+9,307,520
New +$155M 0.66% 33

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Thornburg Investment Management's NVO Position: Q4 2025 in Review

Thornburg Investment Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 544,386 shares — an estimated $30.2M sold.

Thornburg Investment Management first reported a position in NVO in Q2 2013 and held it in 26 quarters. The position peaked at $181M in Q1 2014. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Thornburg Investment Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Thornburg Investment Management sold 544,386 Novo Nordisk shares in Q4 2025, an estimated $30.2M.
  • Thornburg Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 26 quarters.
  • Thornburg Investment Management's Novo Nordisk position peaked at $181M in Q1 2014.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Thornburg Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.